Diagnostic options · UAE

Genetics tests in Dubai & UAE

Compare available Genetics tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

2,789

Listed price range

-1.00–50,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Genetics test prices

Showing 2701–2715 of 2,789 matching tests.

Genetics diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-4049 VPS13A Gene Choreoacanthocytosis Genetic Test This genetic test evaluates the VPS13A gene for mutations associated with choreoacanthocytosis.	Whole blood (3–5 mL in EDTA) or extracted DNA	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["VPS13A gene variants", "Single Nucleotide Variants (SNVs)", "Insertions/Deletions (indels)"] Parameters [] Preparation ["No specific preparation required"] Indications ["Suspected choreoacanthocytosis", "Family history of choreoacanthocytosis", "Diagnostic confirmation"] Measurement technique Confirm with laboratory Codes LOINC: 48834-2 ICD-10: G24.5 Clinical summary This genetic test evaluates the VPS13A gene for mutations associated with choreoacanthocytosis.
TEST-5362 VPS33B Gene Analysis (Next-Generation Sequencing) for Arthrogryposis, Renal Dysfunction, and Cholestasis Type 1 (ARC Syndrome) Test This diagnostic test evaluates the VPS33B gene for mutations associated with Arthrogryposis, Renal dysfunction, and Cholestasis type 1 (ARC syndrome).	Whole blood (peripheral), extracted DNA, or dried blood spot on FTA card	3 to 4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["VPS33B gene sequence", "Variants in exons and flanking intronic regions"] Parameters [] Preparation [] Indications ["Suspected ARC syndrome based on clinical presentation", "Family history of ARC syndrome"] Measurement technique Confirm with laboratory Codes LOINC: 82439-2 ICD-10: Q87.8 Clinical summary This diagnostic test evaluates the VPS33B gene for mutations associated with Arthrogryposis, Renal dysfunction, and Cholestasis type 1 (ARC syndrome).
TEST-4762 VPS45 Gene Severe Congenital Neutropenia Type 5 (Autosomal Recessive) Genetic Test This test identifies pathogenic variants in the VPS45 gene associated with severe congenital neutropenia type 5.	Whole blood (EDTA), extracted DNA, or FTA card	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["VPS45 gene variants", "Pathogenic mutations"] Parameters [] Preparation ["Detailed clinical history focusing on recurrent infections, oral/genital ulcers, neutrophil counts, and family pedigree is mandatory.", "Avoid discontinuing any current treatments; always consult the ordering physician.", "Samples collected on FTA cards must be dried completely before shipment."] Indications ["Clinical suspicion of severe congenital neutropenia type 5", "Family history of autosomal recessive neutropenia", "Genetic counseling of at-risk family members"] Measurement technique Confirm with laboratory Codes LOINC: 21637-6 ICD-10: D70.0 Clinical summary This test identifies pathogenic variants in the VPS45 gene associated with severe congenital neutropenia type 5.
TEST-5503 VPS53 Gene Pontocerebellar Hypoplasia Type 2E Genetic Test This genetic test analyzes the VPS53 gene to detect pathogenic variants associated with Pontocerebellar Hypoplasia Type 2E (PCH2E).	Peripheral Whole Blood	3-4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["VPS53 gene coding region", "Pathogenic variants (SNVs, indels, CNVs)"] Parameters [] Preparation ["No specific fasting required", "Do not discontinue prescribed medication"] Indications ["Definitive diagnosis of PCH2E", "Carrier screening", "Reproductive planning"] Measurement technique Confirm with laboratory Codes LOINC: 98936-4 ICD-10: Q04.8 Clinical summary This genetic test analyzes the VPS53 gene to detect pathogenic variants associated with Pontocerebellar Hypoplasia Type 2E (PCH2E).
TEST-3825 VPS54‑Related Amyotrophic Lateral Sclerosis (ALS) Genetic Test This genetic test identifies pathogenic variants in the VPS54 gene associated with a rare form of autosomal dominant Amyotrophic Lateral Sclerosis (ALS).	Whole Blood (Peripheral)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["VPS54 gene pathogenic variants", "Autosomal dominant ALS risk"] Parameters [] Preparation ["No specific fasting required", "Inform phlebotomist of recent blood transfusion"] Indications ["Individuals with a family history of ALS", "At-risk individuals seeking genetic counseling", "Diagnostic confirmation in suspected cases"] Measurement technique Confirm with laboratory Codes LOINC: 88215-6 ICD-10: G12.21 Clinical summary This genetic test identifies pathogenic variants in the VPS54 gene associated with a rare form of autosomal dominant Amyotrophic Lateral Sclerosis (ALS).
TEST-5492 VRK1 Gene Pontocerebellar Hypoplasia Type 1A Genetic Test This genetic test evaluates the VRK1 gene for pathogenic variants associated with Pontocerebellar Hypoplasia Type 1A.	Whole blood, extracted DNA, or dried blood spot (FTA card)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["VRK1 gene coding region", "Pathogenic variants in VRK1"] Parameters [] Preparation [] Indications ["Infants presenting with microcephaly, cerebellar hypoplasia, and severe psychomotor delay"] Measurement technique Confirm with laboratory Codes LOINC: 95411-6 ICD-10: Q04.8 Clinical summary This genetic test evaluates the VRK1 gene for pathogenic variants associated with Pontocerebellar Hypoplasia Type 1A.
TEST-2921 VSX1 Gene Craniofacial Anomalies and Anterior Segment Dysgenesis Syndrome Genetic Test This test evaluates the VSX1 gene for pathogenic variants associated with craniofacial anomalies and anterior segment dysgenesis syndrome.	Peripheral Whole Blood (Venipuncture)	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Single nucleotide variants in the VSX1 gene", "Small insertions/deletions in the VSX1 gene"] Parameters [] Preparation ["No specific fasting required", "No medication or diet changes needed"] Indications ["Clinical suspicion of craniofacial anomalies and anterior segment dysgenesis syndrome", "Family history of VSX1-related disorders"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: Q87.0 Clinical summary This test evaluates the VSX1 gene for pathogenic variants associated with craniofacial anomalies and anterior segment dysgenesis syndrome.
TEST-3615 VSX1 Gene Sequencing for Posterior Polymorphous Corneal Dystrophy Type 1 Test This test identifies pathogenic DNA variants within the VSX1 gene, confirming a diagnosis of Posterior Polymorphous Corneal Dystrophy Type 1 (PPCD1).	Whole blood (4 mL) or FTA card blood spot	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic DNA variants in the VSX1 gene", "Entire VSX1 coding sequence and adjacent intronic boundaries"] Parameters [] Preparation [] Indications ["Suspected Posterior Polymorphous Corneal Dystrophy Type 1 (PPCD1)", "Family history of PPCD1", "Need for definitive molecular diagnosis"] Measurement technique Confirm with laboratory Codes LOINC: 100228-7 ICD-10: H18.5 Clinical summary This test identifies pathogenic DNA variants within the VSX1 gene, confirming a diagnosis of Posterior Polymorphous Corneal Dystrophy Type 1 (PPCD1).
TEST-2883 WAC Gene Desanto-Shinawi Syndrome Genetic Test This genetic test analyzes the WAC gene for pathogenic variants associated with Desanto-Shinawi Syndrome.	Whole Blood (EDTA), Extracted DNA, or FTA Card	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the WAC gene", "Single nucleotide variants (SNVs)", "Insertions and deletions (indels)", "Copy number variations (CNVs)"] Parameters [] Preparation [] Indications ["Clinical suspicion of Desanto-Shinawi Syndrome", "Evaluation of developmental delay with dysmorphic features"] Measurement technique Confirm with laboratory Codes LOINC: 92822-6 ICD-10: Q87.8 Clinical summary This genetic test analyzes the WAC gene for pathogenic variants associated with Desanto-Shinawi Syndrome.
TEST-3443 Warfarin Sensitivity Detection Test (CYP2C9 & VKORC1 Genotyping) This test evaluates genetic variants in the CYP2C9 and VKORC1 genes that influence an individual's response to warfarin.	Whole Blood (EDTA)	13 Calendar Days	2,500.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CYP2C9 gene variants (2, 3 alleles)", "VKORC1 gene variant (-1639G>A)"] Parameters [{"name": "CYP2C92", "reference_range": null}, {"name": "CYP2C93", "reference_range": null}, {"name": "VKORC1 -1639G>A", "reference_range": null}] Preparation ["No fasting required", "No special preparation required"] Indications ["Patients requiring warfarin therapy", "Patients with atrial fibrillation", "Patients with mechanical heart valves", "Patients with venous thromboembolism"] Measurement technique Confirm with laboratory Codes LOINC: 94477-7 ICD-10: Z13.89 Clinical summary This test evaluates genetic variants in the CYP2C9 and VKORC1 genes that influence an individual's response to warfarin.
TEST-3160 WAS Gene (X‑Linked Intermittent Thrombocytopenia) Genetic Test This test evaluates the entire WAS gene for pathogenic variants associated with X‑linked intermittent thrombocytopenia (XLT). It identifies single nucleotide variants, insertions/d...	Peripheral Whole Blood	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["WAS gene pathogenic variants", "Single nucleotide variants (SNVs)", "Insertions/deletions (indels)", "Exonic rearrangements", "Copy number variations (CNV)"] Parameters [] Preparation ["No specific fasting required", "Inform lab of recent blood transfusions"] Indications ["Suspected X‑linked intermittent thrombocytopenia", "Family history of XLT", "Need for carrier testing", "Genetic counselling for family members"] Measurement technique Confirm with laboratory Codes LOINC: 103204-5 ICD-10: D69.4 Clinical summary This test evaluates the entire WAS gene for pathogenic variants associated with X‑linked intermittent thrombocytopenia (XLT). It identifies single nucleotide variants, insertions/deletions, and copy number variations.
TEST-5818 WASHC5 Gene (SPG8) Genetic Test (NGS) This test evaluates the entire coding sequence of the WASHC5 gene for pathogenic variants associated with Hereditary Spastic Paraplegia type 8 (SPG8).	Whole Blood, Extracted DNA, or FTA Card (Peripheral Blood)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["WASHC5 gene sequence", "Pathogenic variants (mutations)"] Parameters [] Preparation ["No specific fasting required", "No medication or diet changes needed prior to sample collection"] Indications ["Suspected diagnosis of Hereditary Spastic Paraplegia type 8 (SPG8)", "Confirmation of clinical diagnosis", "Genetic counselling for affected families", "Differential diagnosis of spastic paraplegia"] Measurement technique Confirm with laboratory Codes LOINC: 81246-7 ICD-10: G11.4 Clinical summary This test evaluates the entire coding sequence of the WASHC5 gene for pathogenic variants associated with Hereditary Spastic Paraplegia type 8 (SPG8).
TEST-3906 WDPCP Gene Bardet‑Biedl Syndrome Type 15 Genetic Test This test evaluates the WDPCP gene for mutations associated with Bardet‑Biedl syndrome type 15.	Peripheral whole blood (EDTA) or buccal swab; FTA card acceptable for neonates	3–4 weeks from sample receipt	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["WDPCP gene sequence", "Copy Number Variants (CNVs) in WDPCP gene"] Parameters [] Preparation ["No specific fasting required", "Inform lab of any medications"] Indications ["Clinical suspicion of Bardet‑Biedl syndrome type 15", "Family history of Bardet‑Biedl syndrome", "Need for genetic confirmation for diagnosis and management"] Measurement technique Confirm with laboratory Codes LOINC: 21612-7 ICD-10: Q87.89 Clinical summary This test evaluates the WDPCP gene for mutations associated with Bardet‑Biedl syndrome type 15.
TEST-3402 WDR11 Gene Hypogonadotropic Hypogonadism Type 14 Genetic Test This genetic test identifies mutations in the WDR11 gene associated with hypogonadotropic hypogonadism type 14.	Peripheral whole blood or buccal swab	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic and likely pathogenic variants in the WDR11 gene"] Parameters [] Preparation ["No specific fasting required", "Inform phlebotomist of any medications"] Indications ["Diagnosis of hypogonadotropic hypogonadism type 14", "Genetic counselling for affected individuals and families", "Guiding fertility treatments and hormone replacement therapy"] Measurement technique Confirm with laboratory Codes LOINC: 81222-9 ICD-10: E23.0 Clinical summary This genetic test identifies mutations in the WDR11 gene associated with hypogonadotropic hypogonadism type 14.
TEST-3618 WDR19 Gene Nephronophthisis Type 13 Genetic Test This test evaluates the WDR19 gene for pathogenic variants associated with nephronophthisis type 13.	Peripheral whole blood (3-5 mL EDTA tube)	3 to 4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["WDR19 gene coding region", "Flanking intronic regions"] Parameters [] Preparation [] Indications ["Suspected nephronophthisis type 13", "Family history of nephronophthisis type 13", "Multisystem ciliopathy evaluation"] Measurement technique Confirm with laboratory Codes LOINC: 21666-2 ICD-10: Q61.8 Clinical summary This test evaluates the WDR19 gene for pathogenic variants associated with nephronophthisis type 13.

Category overview

Genetics: overview

Understanding your unique biological blueprint offers a profound sense of clarity and empowers proactive health planning for you and your family. At DNA Labs UAE, our specialized Genetics division employs state-of-the-art molecular technologies to provide deep insights into hereditary markers and cellular mutations. This comprehensive genetics testing in the UAE equips your healthcare provider with the precise data needed to tailor your medical guidance effectively. Recognized among top diagnostic labs in Dubai and the UAE, we prioritize your peace of mind through strict confidentiality protocols and exceptionally fast, accurate reporting. Take the next step in your health journey. View our genetics diagnostic services, book a private home collection, or consult our specialized team today.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.

Explore this area

Genetics tests in Dubai & UAE

Genetics test prices

Genetics: overview

Use the test details as a conversation starter

Related Genetics categories